Researchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment ...

This dynamic landscape has driven the creation of a range of immune checkpoint-related products, encompassing high-quality proteins, inhibitor screening kits, stable cell lines, and PK assay kits.

Researchers have developed a groundbreaking AI model that identifies tumor-fighting immune cells, enhancing cancer ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy have developed ...

Korean researchers develop Trojan horse method to produce antibodies in tumors Innovative nanoparticle platform creates tumor ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed ...

Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

New research highlights a link between immune checkpoint inhibitors (ICIs) and an increased risk of autoimmune diseases, including rheumatoid arthritis, emphasizing the need for vigilance among ...

They block the binding of checkpoint proteins with their partner proteins, preventing the "off" signal that stops immune T cells from being activated. "Our research represents a remarkable ...